Strong antitumour effects of FABP4 suggested subsequent exploration of the regulatory mechanism of FABP4 silencing in GC using the TCGA dataset to analyse the effects of CNV, mutations, and DNA methylation on FABP4 expression; however, the results indicated a lack of significant correlations. Here, FABP4 is linked to gastric cancer.